Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123490454 | 12349045 | 4 | F | 20160713 | 20160509 | 20160715 | EXP | US-GILEAD-2016-0212504 | GILEAD | 63.00 | YR | A | M | Y | 0.00000 | 20160715 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123490454 | 12349045 | 1 | PS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 10 UNK, QD | N | 1504767A | 22081 | TABLET | QD | ||||||
| 123490454 | 12349045 | 2 | SS | REMODULIN | TREPROSTINIL | 1 | Unknown | 0.142 UG/KG, UNK | U | 0 | .142 | UG/KG | |||||||
| 123490454 | 12349045 | 3 | SS | ADCIRCA | TADALAFIL | 1 | Unknown | U | 0 | ||||||||||
| 123490454 | 12349045 | 4 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 123490454 | 12349045 | 5 | C | DIAZEPAM. | DIAZEPAM | 1 | 0 | ||||||||||||
| 123490454 | 12349045 | 6 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 0 | ||||||||||||
| 123490454 | 12349045 | 7 | C | TRAMADOL. | TRAMADOL | 1 | 0 | ||||||||||||
| 123490454 | 12349045 | 8 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 123490454 | 12349045 | 9 | C | OXYCODONE | OXYCODONE | 1 | 0 | ||||||||||||
| 123490454 | 12349045 | 10 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 123490454 | 12349045 | 11 | C | POTASSIUM | POTASSIUM | 1 | 0 | ||||||||||||
| 123490454 | 12349045 | 12 | C | LEVOXYL | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 123490454 | 12349045 | 13 | C | DIGOXIN. | DIGOXIN | 1 | 0 | ||||||||||||
| 123490454 | 12349045 | 14 | C | WARFARIN | WARFARIN | 1 | 0 | ||||||||||||
| 123490454 | 12349045 | 15 | C | GLIPIZIDE. | GLIPIZIDE | 1 | 0 | ||||||||||||
| 123490454 | 12349045 | 16 | C | METOLAZONE. | METOLAZONE | 1 | 0 | ||||||||||||
| 123490454 | 12349045 | 17 | C | LASIX | FUROSEMIDE | 1 | 0 | ||||||||||||
| 123490454 | 12349045 | 18 | C | TRADJENTA | LINAGLIPTIN | 1 | 0 | ||||||||||||
| 123490454 | 12349045 | 19 | C | BUMEX | BUMETANIDE | 1 | 0 | ||||||||||||
| 123490454 | 12349045 | 20 | C | CARDIZEM CD | DILTIAZEM HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123490454 | 12349045 | 1 | Pulmonary arterial hypertension |
| 123490454 | 12349045 | 2 | Product used for unknown indication |
| 123490454 | 12349045 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123490454 | 12349045 | DE |
| 123490454 | 12349045 | HO |
| 123490454 | 12349045 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123490454 | 12349045 | Cardiac disorder | |
| 123490454 | 12349045 | Fluid retention | |
| 123490454 | 12349045 | Pain | |
| 123490454 | 12349045 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123490454 | 12349045 | 1 | 20121022 | 20160529 | 0 | |
| 123490454 | 12349045 | 2 | 20160424 | 20160505 | 0 |